Subgroup analyses of maraviroc in previously treated R5 HIV-1 infection.
Fätkenheuer G; Nelson M; Lazzarin A; Konourina I; Hoepelman AI; Lampiris H; Hirschel B; Tebas P; Raffi F; Trottier B; Bellos N; Saag M; Cooper DA; Westby M; Tawadrous M; Sullivan JF; Ridgway C; Dunne MW; Felstead S; Mayer H; van der Ryst E; The New England Journal Of Medicine, 2008, vol. 359, issue 14, p 1442, ISSN 15334406. ISBN 15334406.
Full Text Resources Located for this Citation